Clinical Trial Update: Exploratory Study of MRI Biomarkers of NASH [NA]

View source ↗

Summary

An exploratory MRI biomarker study in non-alcoholic fatty liver disease (NASH), with participant recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease
• Non-alcoholic Steatohepatitis

Snippet

Sponsor: University Hospital, Angers | Conditions: Non-alcoholic Fatty Liver Disease NAFLD | NA | Status: RECRUITING